With a market cap of has a large market cap size. Mylan N.V. (NASDAQ: MYL) has been on the stock market since its IPO date on the 12/18/1987. Mylan N.V. is in the Drugs – Generic industry and Healthcare sector. Average volume for Mylan N.V., is 5761.45, and so far today it has a volume of 5356200. Performance year to date since the 12/18/1987 is -22.21%.
To help you determine whether Mylan N.V. is undervalued the following values will help you decide. P/E is 26.74 and forward P/E is 7.3. PEG perhaps more useful shows that Mylan N.V. has a value for PEG of 2.04. P/S ratio is 2.26 and the P/B ratio is 2.05. The P/Cash and P/Free cash flow is 3.54 and 12.77 respectively.
At the current price Mylan N.V. is trading at, 42.06 (-1.24% today), Mylan N.V. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 1.57, and this is looking to grow in the next year to 16.20% after growing -31.50% this past year. EPS growth quarter over quarter is 2.80%, and 8.00% for sales growth quarter over quarter.
The number of shares outstanding is 534.91, and the number of shares float is 438.9. The senior management bring insider ownership to 0.50%, and institutional ownership is at 64.50%. The float short is 4.90%, with the short ratio at a value of 3.73. Management has seen a return on assets of 3.40%, and also a return on investment of 8.20%.
The ability for Mylan N.V., to deal with debt, means it current ratio is 3.2, and quick ratio is 2.6. Long term debt/equity is 1.24 and total debt/equity is 1.31. In terms of margins, Mylan N.V. has a gross margin of 45.30%, with its operating margin at 15.70%, and Mylan N.V. has a profit margin of 8.10%.
The 52 week high is -24.23%, with 11.89% being its 52 week low. The 20 day simple moving average is -6.57% and the 200 day simple moving average is -9.46%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.